201 related articles for article (PubMed ID: 28084855)
21. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA.
Haschimi B; Grafinger KE; Pulver B; Psychou E; Halter S; Huppertz LM; Westphal F; Pütz M; Auwärter V
Drug Test Anal; 2021 Aug; 13(8):1499-1515. PubMed ID: 33788409
[TBL] [Abstract][Full Text] [Related]
22. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
Krotulski AJ; Mohr ALA; Logan BK
J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
[TBL] [Abstract][Full Text] [Related]
23. A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA.
Schwartz MD; Trecki J; Edison LA; Steck AR; Arnold JK; Gerona RR
J Emerg Med; 2015 May; 48(5):573-80. PubMed ID: 25726258
[TBL] [Abstract][Full Text] [Related]
24. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
25. A case of intoxication with a mixture of synthetic cannabinoids EAM-2201, AB-PINACA and AB-FUBINACA, and a synthetic cathinone α-PVP.
Yamagishi I; Minakata K; Nozawa H; Hasegawa K; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
Leg Med (Tokyo); 2018 Nov; 35():44-49. PubMed ID: 30268690
[TBL] [Abstract][Full Text] [Related]
26. Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
Lam RPK; Tang MHY; Leung SC; Chong YK; Tsui MSH; Mak TWL
Clin Toxicol (Phila); 2017 Aug; 55(7):662-667. PubMed ID: 28393558
[TBL] [Abstract][Full Text] [Related]
27. Testing for AB-PINACA in human hair: Distribution in head hair versus pubic hair.
Arbouche N; Raul JS; Garnier D; Kintz P; Ameline A
Drug Test Anal; 2019 Apr; 11(4):610-616. PubMed ID: 30604522
[TBL] [Abstract][Full Text] [Related]
28. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
Yeter O; Erol Öztürk Y
Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
[TBL] [Abstract][Full Text] [Related]
29. LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows.
Kneisel S; Speck M; Moosmann B; Corneillie TM; Butlin NG; Auwärter V
Anal Bioanal Chem; 2013 May; 405(14):4691-706. PubMed ID: 23535743
[TBL] [Abstract][Full Text] [Related]
30. 5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA.
Angerer V; Franz F; Moosmann B; Bisel P; Auwärter V
Forensic Toxicol; 2019; 37(1):186-196. PubMed ID: 30636986
[TBL] [Abstract][Full Text] [Related]
31. A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry.
Freijo TD; Harris SE; Kala SV
J Anal Toxicol; 2014 Oct; 38(8):466-78. PubMed ID: 25217534
[TBL] [Abstract][Full Text] [Related]
32. In Vivo Metabolites of AB-PINACA in Solid Tissues Obtained from Its Abuser: Comparison with In Vitro Experiment.
Minakata K; Hasegawa K; Yamagishi I; Nozawa H; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
J Anal Toxicol; 2021 Jan; 44(9):1027-1035. PubMed ID: 32232365
[TBL] [Abstract][Full Text] [Related]
33. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
34. Freeze-thaw stability and long-term stability of 84 synthetic cannabinoids in serum.
Hess C; Krueger L; Unger M; Madea B
Drug Test Anal; 2017 Oct; 9(10):1506-1511. PubMed ID: 27863089
[TBL] [Abstract][Full Text] [Related]
35. Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry.
Carlier J; Diao X; Scheidweiler KB; Huestis MA
Clin Chem; 2017 May; 63(5):1008-1021. PubMed ID: 28302730
[TBL] [Abstract][Full Text] [Related]
36. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center.
Katz KD; Leonetti AL; Bailey BC; Surmaitis RM; Eustice ER; Kacinko S; Wheatley SM
West J Emerg Med; 2016 May; 17(3):290-4. PubMed ID: 27330661
[TBL] [Abstract][Full Text] [Related]
37. An outbreak of exposure to a novel synthetic cannabinoid.
Monte AA; Bronstein AC; Cao DJ; Heard KJ; Hoppe JA; Hoyte CO; Iwanicki JL; Lavonas EJ
N Engl J Med; 2014 Jan; 370(4):389-90. PubMed ID: 24450915
[No Abstract] [Full Text] [Related]
38. In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.
Erol Ozturk Y; Yeter O
J Anal Toxicol; 2021 Jan; 44(9):976-984. PubMed ID: 32091101
[TBL] [Abstract][Full Text] [Related]
39. Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.
Shanks KG; Clark W; Behonick G
J Anal Toxicol; 2016 Apr; 40(3):236-9. PubMed ID: 26755539
[TBL] [Abstract][Full Text] [Related]
40. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]